AMLX vs AAPL: Which Stock is Better?
Side-by-side comparison of Amylyx Pharmaceuticals Inc and Apple Inc in 2026
AMLX
Amylyx Pharmaceuticals Inc
$14.29
AAPL
Apple Inc
$252.56
Key Metrics Comparison
| Metric | AMLX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.59B | N/A | AMLX |
| P/E Ratio | N/A | 32.14 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | 13594.6% | 47.3% | AMLX |
Analyze AMLX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMLX or AAPL a better investment?
Comparing AMLX and AAPL: Amylyx Pharmaceuticals Inc has a market cap of $1.59B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMLX and AAPL?
AMLX (Amylyx Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMLX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AMLX or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for AMLX.
Which company is more profitable: AMLX or AAPL?
Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 13594.6% compared to 47.3% for AAPL.
Which is the larger company: AMLX or AAPL?
Amylyx Pharmaceuticals Inc (AMLX) is larger with a market cap of $1.59B compared to N/A for AAPL.
Should I buy AMLX or AAPL in 2026?
Both AMLX and AAPL have investment merit. AMLX trades at $14.29 while AAPL trades at $252.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMLX and AAPL stock?
Key differences: Market Cap ($1.59B vs N/A), P/E Ratio (N/A vs 32.1x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (13594.6% vs 47.3%).